Description:
A drug that contains the active ingredient mitomycin, which comes from the bacterium Streptomyces, and is used to treat adults with a certain type of urothelial cancer. It is given as a solution through a catheter that is placed into the ureter or kidney. Jelmyto damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of alkylating agent.
